Koutny Florian, Wiemann Dagobert, Eckert Alexander, Meyhöfer Svenja, Fritsch Maria, Pappa Angeliki, Wiegand Susanna, Weyer Marc, Wurm Michael, Weghuber Daniel, Holl Reinhard W
Department of Human Medicine, PhD Medical Science, Paracelsus Medical University, Salzburg, Austria.
Department of Internal Medicine 2, Gastroenterology and Hepatology and Rheumatology, Karl Landsteiner University of Health Sciences, University Hospital of St. Pölten, St. Pölten, Austria.
J Pediatr Gastroenterol Nutr. 2024 May;78(5):1027-1037. doi: 10.1002/jpn3.12194. Epub 2024 Apr 1.
Recent studies have suggested a link between type 1 diabetes mellitus (T1D) and metabolic dysfunction associated steatotic liver disease (MASLD) in children and adolescent, but longitudinal evidence is lacking. This study aimed to investigate the potential association between poorly controlled T1D and elevated alanine aminotransferase (ALT), serving as a proxy for MASLD in children and adolescents over time.
The study included 32,325 children aged 2-17 years with T1D from Germany, Austria, and Switzerland who had undergone at least one assessment of liver enzyme levels recorded in the Diabetes-Patienten- Verlaufsdokumentation registry. Multivariable logistic and Cox regression models were calculated to show possible associations between T1D and elevated ALT values (>26 U/L in males, >22 U/L in females) as a proxy for MASLD.
Children with poorly controlled T1D (HbA1c > 11%) exhibited increased odds of elevated ALT values, after adjustment for age, sex, diabetes duration and overweight (odds ratio [OR] 2.54; 95% confidence interval [CI], 2.10-3.10; p < 0.01). This finding is substantiated by a longitudinal analysis, which reveals that inadequately controlled T1D was associated with a higher hazard ratio (HR) of elevated ALT values compared to children with controlled T1D over an observation period extending up to 5.5 (HR: 1.54; 95% CI, 1.19-2.01; p < 0.01).
In conclusion, the current study strongly links poorly controlled T1D in children and adolescents to MASLD irrespective of overweight. This association is not only present cross-sectionally but also increases over time. The study underscores the critical role of effective diabetes management in reducing the risk of MASLD in this population.
近期研究表明儿童和青少年1型糖尿病(T1D)与代谢功能障碍相关脂肪性肝病(MASLD)之间存在联系,但缺乏纵向证据。本研究旨在探讨儿童和青少年中控制不佳的T1D与丙氨酸氨基转移酶(ALT)升高之间的潜在关联,ALT升高可作为MASLD的替代指标,并观察其随时间的变化情况。
该研究纳入了来自德国、奥地利和瑞士的32325名2至17岁的T1D儿童,这些儿童在糖尿病患者病程记录登记处至少接受过一次肝酶水平评估。采用多变量逻辑回归和Cox回归模型来显示T1D与作为MASLD替代指标的ALT值升高(男性>26 U/L,女性>22 U/L)之间的可能关联。
在调整年龄、性别、糖尿病病程和超重因素后,T1D控制不佳(糖化血红蛋白>11%)的儿童ALT值升高的几率增加(优势比[OR] 2.54;95%置信区间[CI],2.10 - 3.10;p < 0.01)。纵向分析证实了这一发现,该分析显示,在长达5.5年的观察期内,与T1D得到控制的儿童相比,T1D控制不佳与ALT值升高的更高风险比(HR)相关(HR:1.54;95% CI,1.19 - 2.01;p < 0.01)。
总之,当前研究有力地表明,儿童和青少年中控制不佳的T1D与MASLD密切相关,与超重无关。这种关联不仅在横断面研究中存在,而且随着时间推移而增加。该研究强调了有效糖尿病管理在降低该人群MASLD风险方面的关键作用。